Additionally, diverse single nucleotide polymorphisms of p21 are reported to influence the risk of developing cancers including esophageal [151], colorectal and estrogen-related cancer [152], associated with a higher risk of second primary malignancies in head and neck carcinoma [153]. The gene discussed is CDKN1A; the disease is cancer.